pharma
Dermira terminates acne drug after Phase 3 failure, wiping $667m from market value
March 5, 2018Manufacturing and Production, Research and Development Dermira, acne, pharma, trial failure
Skin specialist biopharma firm Dermira has seen its stock crash and burn following the announcement that it plans to terminate …
Uncovering trends in the future of real world data
March 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, feature, pharma, real world data, real world evidence
A new report has canvassed the intentions of industry players in the use of real world data and evidence over …
Gilead investigational data gives hope for HIV eradication in humans
March 5, 2018Research and Development, Sales and Marketing Gilead, HIV, pharma
Gilead has lifted the curtain on new preclinical data on the efficacy of a combo therapy of GS-9620, its investigational …
FDA finds major manufacturing issues at key Aurobindo facility
March 5, 2018Manufacturing and Production, Sales and Marketing Aurobindo, FDA, pharma
Indian pharmaceutical firm Aurobindo has been rocked by an USFDA review which identified nine major issues with its Unit 4 …
Celgene strikes $101m partnership in oncology, neurodegenerative and inflammatory
March 5, 2018Research and Development, Sales and Marketing Cancer, Celgene, Vividion, inflammatory, neurodegenerative, oncology, pharma
Celgene has inked a new multi-year partnership with biotech firm Vividion Therapeutics to leverage the latter’s proteomics and chemistry platforms …
NHS trials “world-leading” initiative to cut prostate cancer diagnoses to just days
March 5, 2018Research and Development, Sales and Marketing Cancer, MRI, NHS, pharma, prostate cancer
The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …
Abbvie and Biogen pull MS drug Zinbryta following urgent EMA safety review
March 5, 2018Sales and Marketing AQbbvie, Biogen, EMA, Europe, mulyiple sclerosis, pharma, zinbryta
Biogen and Abbvie have announced their intention to voluntarily withdraw their multiple sclerosis therapy Zinbryta (daclizumab) from all global markets …
Endo granted injunction to block blood pressure competitor
March 2, 2018Medical Communications, Sales and Marketing Endo, QuVa, Vasostrict, blood pressure, pharma, vasopressin
Generics and speciality pharma firm Endo International has revealed that it has been granted a preliminary injunction to block competitor …
Study identifies five kinds of diabetes, potentially changing treatment
March 2, 2018Medical Communications, Research and Development biotech, diabetes, drugs, pharma, pharmaceutical
A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic …
Artificial Cell Technologies CFO accused of stealing nearly $1m in company funds
March 2, 2018Medical Communications, Sales and Marketing Artificial Cell Technologies, cfo, pharma
A high-ranking C-level executive of a US biotech start-up has been charged with embezzling almost $1 million from the company …
Novartis forms a Pear to develop mobile therapies
March 2, 2018Medical Communications, Research and Development Novartis, Pear Therapeutics, biotech, drugs, pharma, pharmaceutical
Novartis has announced an agreement between Pear Therapeutics and itself to develop two digital therapeutics, one in schizophrenia and one …
Ipsen: Becoming a “development powerhouse”
March 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma
Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …
Takeda to create 70 jobs with €25m Dublin investment
March 1, 2018Manufacturing and Production Dublin, Takeda, pharma
Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a …
Merck/Pfizer’s Bavencio wins slight reprieve after NICE nod
March 1, 2018Medical Communications, Sales and Marketing Bavencio, Merck, Pfizer, biotech, drugs, pharma, pharmaceutical
Just two weeks ago, Merck KGaA and Pfizer were hit with a major setback for their PD-L1 immunotherapy, Bavencio, after …
Europe approves first therapy for haemophilia A with inhibitors in over 20 years
March 1, 2018Research and Development Europe, European Commission, Hemlibra, Roche, haemophilia, pharma
Roche has revealed that its bispecific factor IXa- and factor X-directed antibody Hemlibra (emicizumab) has been approved by the European …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
